ClinicalTrials.Veeva

Menu

Posterior Capsule Opacification (PCO) With AcrySof Single-Piece IOL

I

Iladevi Cataract and IOL Research Center

Status

Completed

Conditions

Posterior Capsule Opacification

Treatments

Procedure: Phaco

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

The purpose of this study what to evaluate if axial myopia might influence the development of PCO.

Full description

We sought to prospectively compare PCO in eyes with myopia in relation to axial length with PCO in eyes with normal axial length, to decipher the role of axial myopia in PCO 4 years after surgery for senile cataract.

Enrollment

100 patients

Sex

All

Ages

50 to 70 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • local residency and presence of a cataract in an otherwise normal eye.
  • Patients older than 50 years
  • a dilated pupil after mydriasis
  • Patients with retinochoroidal atrophy, retinal laser prophylaxis,
  • hypertension

Exclusion criteria

  • nondilating pupil after maximal dilation;
  • pseudoexfoliation; mature, traumatic, black, or complicated cataracts;
  • previous intraocular surgery;
  • previous surgery for glaucoma;
  • uveitis
  • diabetes mellitus
  • Patients who did not give consent preoperatively

Trial design

Primary purpose

Treatment

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

100 participants in 2 patient groups

1. MYOPIA
Experimental group
Description:
axial length \> 26.00 mm
Treatment:
Procedure: Phaco
2. Emmetropia
Active Comparator group
Description:
emmetropic eyes- eyes with an axial length of 21.00 to 23.99 mm
Treatment:
Procedure: Phaco

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems